InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC

IRWD Clue Score47
United States Fiscal year ends December CIK 0001446847 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Alexander J Denner
17 Mar 2026
Director
Sell indirect
5,800
$3.31
$19.20K
Alexander J Denner
17 Mar 2026
Director
Sell indirect
6,725,000
$3.05
$20.51M
Ronald Silver
24 Feb 2026
Principal Accounting Officer
Sell
12,621
$3.66
$46.19K
Gregory S. Martini
24 Feb 2026
Chief Financial Officer
Sell
11,457
$3.66
$41.93K
Thomas A MCCOURT
24 Feb 2026
Chief Executive Officer
Sell
103,526
$3.66
$378.91K
Tammi L Gaskins
24 Feb 2026
Chief Commercial Officer
Sell
11,239
$3.66
$41.13K
Michael Shetzline
24 Feb 2026
SVP, CMO, Head-Res&Drug
Sell
17,012
$3.66
$62.26K
Minardo John
24 Feb 2026
Chief Legal Officer
Sell
19,053
$3.66
$69.73K
Ronald Silver
23 Feb 2026
Principal Accounting Officer
Sell
11,552
$3.81
$44.01K
Gregory S. Martini
23 Feb 2026
Chief Financial Officer
Sell
10,487
$3.81
$39.96K
Thomas A MCCOURT
23 Feb 2026
Chief Executive Officer
Sell
94,757
$3.81
$361.02K
Tammi L Gaskins
23 Feb 2026
Chief Commercial Officer
Sell
10,287
$3.81
$39.19K
Michael Shetzline
23 Feb 2026
SVP, CMO, Head-Res&Drug
Sell
15,570
$3.81
$59.32K
Minardo John
23 Feb 2026
Chief Legal Officer
Sell
17,439
$3.81
$66.44K
Tammi L Gaskins
17 Nov 2025
Chief Commercial Officer
Sell
6,016
$3.32
$19.97K
Show all 18 transactions →

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 1,743,009
History held since 4 Feb 2010